Weight loss in older adults

Reviews in Endocrine and Metabolic Disorders

Volumn 6, Issue 2, 2005, Pages 129-136

  Thomas, David R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CORTICOSTEROID; DEXAMETHASONE; FLUOXYMESTERONE; HYDRAZINE SULFATE; MEGESTROL ACETATE; OXYMETHOLONE; RECOMBINANT GROWTH FACTOR; THALIDOMIDE;

AGE DISTRIBUTION; ANOREXIA; BODY MASS; CACHEXIA; CALORIC INTAKE; CLASSIFICATION; DEATH; DIETARY INTAKE; ELDERLY CARE; ENERGY EXPENDITURE; HUMAN; MORTALITY; MUSCLE ATROPHY; NURSING HOME; REVIEW; SEX DIFFERENCE; STARVATION; WEIGHT REDUCTION;

AGED; AGING; ANOREXIA; BODY MASS INDEX; CACHEXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NUTRITIONAL SUPPORT; RANDOMIZED CONTROLLED TRIALS; STARVATION; WEIGHT LOSS;

EID: 18044386533     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-005-6725-6     Document Type: Review

References (83)

1. Landi F, Zuccala G, Gambassi G, Incalzi RA, Manigrasso L, Pagano F, Carbonin P, Bernabei R. Body mass index and mortality among older people living in the community. Journal of the American Geriatrics Society 1999;47:1072-1076.
2. Calle EE, Thum MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass Index and mortality in a prospective cohort of U.S. adults. New Engl J Med 1999;341:1097-1105.
3. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. Journal of the American Geriatrics Society 1995;43:329-337.
4. Payette H, Coulombe C, Boutier V, Gray-Donald K. Weight loss and mortality among tree-living trail elders: a prospective study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 1999;54:M440-M445.
5. Launer LJ, Harris LT, Rumpel C, Madans J. Body mass index, weight change and risk of mobility disability in middle-aged and older women. JAMA 1994;271:1083-1098.
6. Sullivan DH, Bopp MM, Roberson PK. Protein-energy undernutrition and life-threatening complications among the hospitalized elderly. Journal of General Internal Medicine 2002;17:923-932.
7. Galanos AN, Pieper CF, Kussin PS, Winchell MT, Fulkerson WJ, Harrell FE Jr, Teno JM, Layde P, Connors AF Jr, Phillips RS, Wenger NS. Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. Critical Care Medicine 1997;25:1962-1968.
8. Murden RA, Ainslie NK. Recent weight loss is related to short-term mortality in nursing homes. Journal of General Internal Medicine 1994;9:648-650.
9. Sullivan DH, Johnson LE, Bopp MM, Roberson PK. Prognostic significance of monthly weight fluctuations among older nursing home residents. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M633-M639.
10. Ryan C, Bryant E, Eleazer P, Rhodes A, Guest K. Unintentional weight loss in long-term care: predictor of mortality in the elderly. Southern Medical Journal 1995;88:721-724.
11. Long Term Care Facility Resident Assessment Instrument (RAI) User's Manual. Natick, MA: Eliot Press, 1999.
12. Cornoni-Huntley JC, Harris TB, Everett DF, Albanes D, Micozzi MS, Miles TP, Feldman JJ. An overview of body weight of older persons, including the impact on mortality. The National Health and Nutrition Examination Survey I-Epidemiologic Follow-Up Study. J Clin Epidemiol 1991;44:743-753.
13. Losonczy KG, Harris TB, Cornoni-Huntley J, Simonsick EM, Wallace RB, Cook NR, Ostfeld AM, Blazer DG. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? Am J Epidemiol 1995;141:312-321.
14. Diehr P, Bild DE, Harris, Tamara B, Duxbury A, Siscovick D, Rossi M. Body Mass Index and Mortality in Nonsmoking Older Adults: The Cardiovascular Health Study. American Journal of Public Health 1998;88:623-629.
15. Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L. Body mass index and mortality among nonsmoking older persons: The Framingham study. JAMA 1988;259:1520-1524.
16. Pamuk ER, Williamson DF, Serdula MK, Madans J, Byers TE. Weight loss and subsequent death in a cohort of U.S. adults. Annals of Internal Medicine 1993;119:744-748.
17. Diehr P, Bild DE, Harris, Tamara B, Duxbury A, Siscovick D, Rossi M. Body Mass Index and Mortality in Nonsmoking Older Adults: The Cardiovascular Health Study. American Journal of Public Health 1998;88:623-629.
18. Rumpel C, Harris TB, Madans J. Modification of the relationship between the Quetelet Index and mortality by weight-loss history among older women. Ann Epidemiol 1993;3:448-450.
19. Andres R, Muller DC, Sorkin JD. Long-term effects of change in body weight on all-cause mortality. A review. Ann Intern Med 1993;119:737-743.
20. Williamson DF, Pamuk ER. The association between weight loss and increased longevity. A review of the evidence. Ann Intern Med 1993;119:731-736.
21. Blair SN, Shaten J, Brownell K, Collins G, Lissner L. Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med 1993;119:749-757.
22. Lissner L, Odell PM, D'Agostino RB, Stokes J 3rd, Kreger BE, Belanger AJ, Brownell KD. Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991;324:1839-1844.
23. Serdula MK, Mokdad AH, Williamson DF, Galuska DA, Mendlein JM, Heath GW. Prevalence of attempting weight loss and strategies for controlling weight. JAMA 1999;282:1353-1358.
24. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Annals of Internal Medicine 2003;138:383-389.
25. Velthuis-te Wierik EJ, van den Berg H, Schaafsma G, Hendriks HF, Brouwer A. Energy restrictions, a useful intervention to retard human ageing? Results of a feasibility study. Eur J Clin Nutr 1994;48:138-148.
26. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
27. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-1459.
28. Weintraub MS, Rosen Y, Otto R, Eisenberg S, Breslow SL. Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation 1989;79:1007-1014.
29. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. New England Journal of Medicine 1997;336:1117-1124.
30. Leserman J, Stuart EM, Mamish ME, Deckro JP, Beckman RJ, Friedman R, Benson H. Nonpharmacologic intervention for hypertension: long-term follow-up. J Cardiopulm Rehabil 1989;9:316-324.
31. Gaesser GA. Thinness and weight loss: beneficial or detrimental to longevity? Science in Sports & Exercise 1999;31:1118-1128.
32. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. Journal of the American Geriatrics Society 1995;43:329-337.
33. Wilson MM, Vaswani S, Liu D, Morley JE, Miller DK. Prevalence and causes of undernutrition in medical outpatients. American Journal of Medicine 1998;104:56-63.
34. Thomas DR, Ashmen W, Morley JE, Evans JE. Nutritional management in long-term care: development of a clinical guideline. Journal of Gerontology: Medical Sciences 2000;55:725-734.
35. Chapman KM, Nelson RA. Loss of appetite: managing unwanted weight loss in the older patient. Geriatrics 1994;49:54-59.
36. Weinsier RL, Hunker EM, Krumdieck CL, Butterworth CE Jr. Hospital malnutrition: a prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr 1979;32:418-426.
37. Wright BA. Recent weight loss is related to short-term mortality in nursing homes. J Gen Intern Med 1994;9:648-650.
38. Morley JE, Thomas DR. Anorexia and aging: pathophysiology. Nutrition 1999;15:499-503.
39. Plata-Salaman CR. Anorexia during acute and chronic disease. Nutrition 1996;12:69-76.
40. Hedlund J, Hansson LO, Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scandinavian Journal of Infectious Diseases 1995;27:32-37.
41. Morley JE. Decreased food intake with aging. Journals of Gerontology: Medical Sciences 2001;56:81-88.
42. Morley JE, Thomas DR. Update: guidelines for the use of orexigenic drugs in long-term care. Annals of Long-Term Care 2004;6S:1-10.
43. Mathey MRAM, Siebelink E, de Graaf C, Van Staveren WA. Flavor inhancement of food improves dietary intake and nutritional status of elderly nursing home residents. Journals of Gerontology: Medical Sciences 2001;56:M200-M205.
44. Mowe M, Bohmer T, Kindt E. Reduced nutritional status in an elderly population (>70 y) is probable before disease and possibly contributes to the development of disease. American Journal of Clinical Nutrition 1994;59:317-324.
45. Incalzi RA, Gemma A, Capparella O, Cipriani L, Landi F, Carbonin P. Energy intake and in-hospital starvation. A clinically relevant relationship. Archives of Internal Medicine 1996;156:425-429.
46. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999;107:123-126.
47. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763.
48. Melton, LJ III, Khosla S, Riggs BL. Epidemiology of Sarcopenia. Mayo Clinic Proceedings 2000;75:S10-S13.
49. Thomas DR. Distinguishing starvation from cachexia. Geriatric Clinics of North America 2002;18:883-892.
50. Espat NJ, Moldawer LL, Copeland EM 3rd. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. Journal of Surgical Oncology 1995;58:77-82.
51. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Critical Care Medicine 1998;26:1164-1172.
52. Baldwin C, Parsons T, Logan S. Dietary advice for illness-related malnutrition in adults. Cochrane Database of Systematic Reviews 2004;3.
53. Milne AC, Potter J, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. The Cochrane Database of Systematic Reviews 2004;4.
54. Haddad RY, Thomas DR. Enteral Nutrition and Tube Feeding: A Review of the evidence. Geriatric Clinics of North America 2002;18:867-882.
55. Campos ACL, Meguid MM. A critical appraisal of the usefulness of perioperative nutritional support. Am J Clin Nutr 1992;55:117-130.
56. Mitchell, SL, Kiely, DK, Lipsitz LA. The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 1997;157:327-332.
57. Moertel CG, Schutt AJ, Reiteneier RJ, Hahn RG. Corticosteroid therapy of pre-terminal gastrointestinal cancer. Cancer 1974;33: 1607-1609.
58. Willox J, Corr J, Shaw J, Richardson M, Calman KC, Drennan M. Prednisolone as an appetite stimulant in patients with cancer. British Medical Journal 1984;288:200-227.
59. Bruera E. Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisoloone in terminal cancer patients: a prospective randomized double blind study. Cancer Treatment Reports 1985;69:751-754.
60. Robusteli Della Cuna G, Pellegrini A, Piazzi M. Effect of methyl-prednisoloone sodium succinate on quality of life in pre-terminal cancer patients: a placebo controlled multicenter study. European Journal of Cancer & Clinical Oncology 1989;25:1823-1829.
61. Popiela T, Lucchi R, Giongo F. Methlyprednisolone as palliative therapy for female terminal cancer patients. European Journal of Cancer & Clinical Oncology 1989;25;1823-1824.
62. Plassee TF, Gorter RW, Krasnow SH, Lane M, Shepard KV, Wadleigh R. Recent clinical experience with dronabinol. Pharmacology, Biochemistry & Behavior 1991;40:695-700.
63. Nelson K, Walsh D, Deeter P, Sheehan F. A phase II study of delta-nine-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of Palliative Care 1994;10:14-18.
64. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain & Symptom Management 1995;10:89-97.
65. Reyes-Teran G, Sieira-Madero JG, Martinez del Cerro V, Arroyo-Figueroa H, Pasquetti A, Calva JJ, Ruiz-Palacios GM. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS 1996;10:1501-1507.
66. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Annals of Internal Medicine 1996;125:873-882.
67. Morley JE, Kaiser FE, Perry HM, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism: Clinical & Experimental 1997;46:410-413.
68. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing & Development 1999;107:123-136.
69. Morley JE, Distiller LA, Lissoos I, Lipschitz R, Kay G, Searle DL, Katz M. Testicular function in patients with spinal cord damage. Hormone & Metabolic Research 1979;11:679-682.
70. Rudman D, Mattson DE, Nagraj HS, Feller AG, Jackson DL, Rudman JW. Plasma testosterone in nursing home men. Journal of Clinical Epidemiology 1988;41:231-236.
71. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL. Effects of testosterone replacement in hypogonadal men. Journal of Clinical Endocrinology & Metabolism 2000;85:2670-2677.
72. Morley JE, Perry HM 3rd, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. Journal of the American Geriatrics Society 1993;41:149-152.
73. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. Journal of Clinical Endocrinology & Metabolism 1997;82:1661-1667.
74. Bakhshi V, Elliott M, Gentili A, Godschalk M, Mulligan T. Testosterone improves rehabilitation outcomes in ill older men. Journal of the American Geriatrics Society 2000;48:550-553.
75. Hengge UR, Baumann M, Maleba R, Brockmeyer NH, Goos M. Oxymetholone promotes weight gain in patients with advance human immunodeficiency vires (HIV-1) infection. British Journal of Nutrition 1996;75:129-138.
76. Pengelly CD. Oxymetholone in the chemotherapy of malignant disease. Current Medical Research & Opinion 1973;1(7):401-106.
77. Standards, Options and Recommendations for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC) Bulletin du Cancer 2000;87:315-328.
78. Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 1997;12:913-919.
79. Tchekmedyian NS, Tait N, Moody M, Aisner J. High dose megestrol acetate: a possible treatment of cachexia. JAMA 1987;257:1195-1199.
80. Cruz JM, Muss HB, Brockschmidt JK, Evans GW. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard vs. a high does therapy. Seminars in Oncology 1990;17(Suppl):63-67.
81. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Journal of Clinical Oncology 1999;17:3299-3306.
82. Pascual LA, Roque FM, Urrutia CG, Berenstein EG, Almenar PB, Balcells AM, Herdman M. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. Journal of Pain & Symptom Management 2004;27:360-369.
83. Yeh SS, Wu SY, Lee TP, Olson JS, Stevens MR, Dixon T, Porcelli RJ, Schuster MW. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study. Journal of the American Geriatrics Society 2000;48:485-492.